15 Oct 2024

The Power of Social Listening in Real-World Evidence (RWE) Research

2024-10-22T14:59:08+02:00October 15, 2024|All, Other|

The landscape of healthcare research is rapidly evolving, and social media is emerging as a valuable resource for real-world evidence (RWE) studies.

In one of Quantify’s publications, 𝐒𝐨𝐜𝐢𝐚𝐥 𝐌𝐞𝐝𝐢𝐚 𝐋𝐢𝐬𝐭𝐞𝐧𝐢𝐧𝐠 𝐟𝐨𝐫 𝐑𝐞𝐚𝐥-𝐖𝐨𝐫𝐥𝐝 𝐄𝐯𝐢𝐝𝐞𝐧𝐜𝐞: 𝐀 𝐍𝐨𝐯𝐞𝐥 𝐀𝐩𝐩𝐫𝐨𝐚𝐜𝐡 𝐭𝐨 𝐇𝐞𝐚𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐏𝐚𝐭𝐢𝐞𝐧𝐭’𝐬 𝐕𝐨𝐢𝐜𝐞, […]

10 Oct 2024

Use Cases for Literature Reviews Across the Pharmaceutical Product development Lifecycle

2024-10-16T16:19:20+02:00October 10, 2024|All, Other|

Literature reviews are essential throughout the pharmaceutical product development lifecycle, from identifying therapeutic targets to assisting with regulatory and health technology assessment submissions and ultimately improving drug safety and patient outcomes at every stage.

This image presents the use cases for […]

2 Oct 2024

Nordic RWE in FDA decision making

2024-10-02T15:54:31+02:00October 2, 2024|All, Other|

The use of Real-World Data (RWD) to support regulatory decisions is growing rapidly.
Several regulating agencies have in the past few years issued guidelines on the requirements on Real-World Evidence (RWE)-studies to be fit-for purpose for regulatory purposes.

Nordic data properties share […]

1 Oct 2024

COHERE Finland!

2024-10-02T15:59:02+02:00October 1, 2024|Other|

On September 17th, Quantify Finland participated in the Council for Choices in Health Care in Finland (COHERE Finland)10th anniversary seminar. The theme of the seminar was “Prioritization and the service portfolio in 2030.”
The day featured several thought-provoking presentations with highlights […]

Go to Top